StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a research report report published on Sunday. The brokerage issued a hold rating on the stock.
China Pharma Stock Performance
Shares of CPHI stock opened at $0.25 on Friday. The company has a quick ratio of 0.25, a current ratio of 0.89 and a debt-to-equity ratio of 0.17. The stock’s fifty day simple moving average is $0.29 and its 200 day simple moving average is $0.39. China Pharma has a one year low of $0.24 and a one year high of $2.05.
China Pharma (NYSE:CPHI – Get Free Report) last announced its earnings results on Wednesday, May 15th. The company reported ($0.07) EPS for the quarter. China Pharma had a negative return on equity of 54.31% and a negative net margin of 55.42%. The business had revenue of $1.37 million during the quarter.
China Pharma Company Profile
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Featured Stories
- Five stocks we like better than China Pharma
- How to Invest in Small Cap Stocks
- Stock Impact: McDonald’s Price War with Starbucks, Wendy’s
- Consumer Discretionary Stocks Explained
- General Mills Q4 Sales Miss Expectations, Triggering Stock Drop
- What to Know About Investing in Penny Stocks
- Enovix Stock Rises 35% in Short-Squeeze: This Rally Has Legs
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
